Gao Lanmei, Xiong Meilian, Chen Xiaojie, Han Zewen, Yan Chuan, Ye Rongping, Zhou Lili, Li Yueming
Department of Radiology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
The School of Medical Technology and Engineering, Fujian Medical University, Fuzhou, Fujian, China.
Front Oncol. 2022 Apr 27;12:818681. doi: 10.3389/fonc.2022.818681. eCollection 2022.
OBJECTIVES: Microvascular invasion (MVI) affects the postoperative prognosis in hepatocellular carcinoma (HCC) patients; however, there remains a lack of reliable and effective tools for preoperative prediction of MVI. Radiomics has shown great potential in providing valuable information for tumor pathophysiology. We constructed and validated radiomics models with and without clinico-radiological factors to predict MVI. METHODS: One hundred and fifteen patients with pathologically confirmed HCC (training set: n = 80; validation set: n = 35) who underwent preoperative MRI were retrospectively recruited. Radiomics models based on multi-sequence MRI across various regions (including intratumoral and/or peritumoral areas) were built using four classification algorithms. A clinico-radiological model was constructed individually and combined with a radiomics model to generate a fusion model by multivariable logistic regression. RESULTS: Among the radiomics models, the model based on T2WI and arterial phase (T2WI-AP model) in the volume of the liver-HCC interface (VOI) exhibited the best predictive power, with AUCs of 0.866 in the training group and 0.855 in the validation group. The clinico-radiological model exhibited good efficacy (AUC: 0.819 and 0.717, respectively). The fusion model showed excellent predictive ability (AUC: 0.915 and 0.868, respectively), outperforming both the clinico-radiological and the T2WI-AP models in the training and validation sets. CONCLUSION: The fusion model of multi-region radiomics achieves an enhanced prediction of the individualized risk estimation of MVI in HCC patients. This may be a beneficial tool for clinicians to improve decision-making in personalized medicine.
目的:微血管侵犯(MVI)影响肝细胞癌(HCC)患者的术后预后;然而,术前预测MVI仍缺乏可靠有效的工具。放射组学在为肿瘤病理生理学提供有价值信息方面显示出巨大潜力。我们构建并验证了包含和不包含临床放射学因素的放射组学模型来预测MVI。 方法:回顾性纳入115例术前接受MRI检查且病理确诊为HCC的患者(训练集:n = 80;验证集:n = 35)。使用四种分类算法构建基于不同区域(包括瘤内和/或瘤周区域)多序列MRI的放射组学模型。单独构建临床放射学模型,并通过多变量逻辑回归将其与放射组学模型相结合以生成融合模型。 结果:在放射组学模型中,基于肝-HCC界面(VOI)体积的T2WI和动脉期的模型(T2WI-AP模型)表现出最佳预测能力,训练组和验证组的AUC分别为0.866和0.855。临床放射学模型显示出良好的效能(AUC分别为0.819和0.717)。融合模型显示出优异的预测能力(AUC分别为0.915和0.868),在训练集和验证集中均优于临床放射学模型和T2WI-AP模型。 结论:多区域放射组学的融合模型实现了对HCC患者MVI个体化风险估计的增强预测。这可能是临床医生改善个性化医疗决策的有益工具。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022-8-28
J Hepatocell Carcinoma. 2024-11-4
Nat Rev Dis Primers. 2021-1-21
Radiology. 2021-3